Searched for
JSC BIOSINTEZ
Sun Pharma rises 2% as USFDA issues 7 observations on Mohali sitePrabhudas Lilladher said the current price still does not reflect key positives like Ranbaxy integration benefits, Halol plant resolution a...25 Nov, 2016, 01.06 PM IST- Sun Pharma to acquire 85 per cent stake in Russia's BiosintezBiosintez focuses on the hospital segment with annual revenues of about USD 52 million for 2015.24 Nov, 2016, 01.29 AM IST
Load More